A comparative study focused on levels of MBL and MASPs in patients with cardiovascular and cerebrovascular diseases observed that patients with a recent myocardial infarction had higher serum MASP-1 levels than healthy controls, coronary artery disease (CAD) patients, and stroke patients. The gene discussed is MBL2; the disease is coronary artery disorder.